STAT

SEPTEMBER 4, 2024

With fall coming into view, public health officials across the country are turning to the annual task of persuading legions of Americans to get vaccinated against some combination of influenza, Covid-19, and respiratory syncytial virus, three bugs that sicken mass numbers of people over the winter months, often overwhelming hospitals and health care delivery in the process.

Vaccines 363

Vaccines Hospitals 363

PharmaVoice

SEPTEMBER 4, 2024

More companies are investing in protein degraders, which leverage a unique approach to harnessing the immune system in cancer, neurological diseases and more.

Immunization 147

Immunization Immunity 147

STAT

SEPTEMBER 4, 2024

The emergence of a second mpox outbreak in which the virus is spreading from person-to-person, as well as a sharp increase in overall cases of the disease in several African countries, is straining the world’s capacity to make and distribute vaccine to battle the threat. New options are needed, and a study published Wednesday suggests another may be on the horizon.

Vaccines 357

Vaccines 357

PharmaVoice

SEPTEMBER 4, 2024

Results from Vaxcyte’s clinical pneumococcal vaccine study showed the smaller company could take on Pfizer’s legendary blockbuster.

Vaccines 130

Vaccines 130

Speaker: Joe Sharpe and James Carlson

In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.

STAT

SEPTEMBER 4, 2024

There it was on James Cannon’s lab report, two tiny words: African American. The words sat next to a number estimating how badly Cannon’s kidneys were failing. And they were definitely failing. His number read 37, less than half of what is considered normal for adults. Oddly, he thought, a different number labeled “if not African American” read even lower: 31.

Labelling 343

Labelling 343

BioPharma Dive

SEPTEMBER 4, 2024

Over the past 10 years, PD1-blocking medicines have transformed cancer care. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Pharmaceutical Companies 140

Pharmaceutical Companies Pharmaceutical Companies 140

BioPharma Dive

SEPTEMBER 4, 2024

The funding comes amid a slowdown in venture investment for gene and cell therapy startups, and will support development of multiple solid tumor programs.

130

130

STAT

SEPTEMBER 4, 2024

A typical vending machine on a university campus might offer students the usual range of sodas, Sunchips, and Skittles. But a vending machine installed earlier this year at SUNY Upstate Medical University in Syracuse, New York, has a unique offering: Plan B pills. The vending machine, located in the campus library, is an effort to ensure that emergency contraceptives are affordable and accessible to the student body, with the Plan B pill costing as little as $10, compared to typical costs of $40

321

321

pharmaphorum

SEPTEMBER 4, 2024

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).The full results of the FENopta open-label extension study are due to be reported in full at the ECTRIMS congress in Copenhagen later this month, but top-line findings include that 99% of patients treated with fenebrutinib were free of T1 gadolinium-enhancing lesions, markers of active inflammation, at 48 w

Labelling 105

Labelling 105

STAT

SEPTEMBER 4, 2024

When you have a baby, sleep becomes the holy grail. You become convinced that getting your baby to go the hell to sleep depends on the right swaddles, the right pacifier, the right settings on the white noise machine, the right order of events. If a routine gets disrupted or a special object misplaced, you fear that the kid will be awake for days, and thus, so will you.

307

307

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Technology

SEPTEMBER 4, 2024

By integrating the best practices from decentralized trials, CROs can optimize efficiencies and streamline site-based operations, ensuring that site-centric trials remain effective and innovative.

98

98

STAT

SEPTEMBER 4, 2024

Novartis is opening a new manufacturing facility in California and expanding an existing production site in its bid to dominate the booming radiopharmaceuticals field amid burgeoning competition. The pharmaceutical giant will spend more than $200 million to construct the new facility in Carlsbad, Calif., and expand its site in Indianapolis, representatives told STAT exclusively.

Drug Development 291

Drug Development 291

Drug Patent Watch

SEPTEMBER 4, 2024

Optimizing API manufacturing is crucial for ensuring the consistent production of high-quality APIs. The pharmaceutical industry has learned valuable lessons from various strategies and technologies that have significantly improved the efficiency, precision, and sustainability of API manufacturing processes. De-risking involves minimizing the uncertainty and unknowns in an API strategy.

97

97

STAT

SEPTEMBER 4, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! Is your blue my blue? The STAT newsroom was lit up over this existential question yesterday. This test attempts to determine at which hue you perceive the boundary between green and blue to be. The more design-oriented staffers especially didn’t like the binary nature of the task.

285

285

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Pharmacist

SEPTEMBER 4, 2024

Primary care staff need urgent support and training to care for people with food allergies, according to researchers who found that numbers have doubled since 2008. An analysis published in The Lancet Public Health said the largest rise had been seen in young children but the reasons behind the trend were not clear. In a study of […] The post Primary care staff need more support to manage rise in food allergies, say researchers appeared first on The Pharmacist.

96

96

STAT

SEPTEMBER 4, 2024

Depression has many faces. Some people can’t sleep, while others struggle to get out of bed. Even though symptoms and severity can vary from person to person, a recent study found that a specific brain circuit might be associated with the mental malady.  Located in the prefrontal cortex, the brain’s cognitive control circuit plays a part in our attention, goal-setting behavior and other executive functioning.

268

268

The Pharmacist

SEPTEMBER 4, 2024

The recruitment of pharmacists and other additional roles into general practice is slowing, the latest figures from the National Workforce Reporting Service (NWRS) suggest. Pharmacists remain the most popular Additional Roles Reimbursement Scheme (ARRS) role, but recruitment has slowed dramatically since the beginning of this financial year. And the primary care network (PCN) pharmacist workforce […] The post ARRS recruitment slowing across the board, data suggests appeared first on The Ph

94

94

STAT

SEPTEMBER 4, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. If your local deserted mall were to be shut down, would you rather it be turned into a shiny new arena for your basketball team or a shiny new biomedical innovation hub? That’s apparently the dilemma the business community is facing in Philadelphia.

Drug Pricing 245

Drug Pricing Drug Development 245

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Express Pharma

SEPTEMBER 4, 2024

STEER World announced the appointment of Dhiraj Tiwari as Chief Financial Officer. As CFO, Tiwari will oversee STEER World’s financial operations, including budgeting, forecasting, reporting, and auditing. In addition to overseeing finance and accounting, Dhiraj will serve on STEER World’s executive team. Tiwari brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG.

90

90

STAT

SEPTEMBER 4, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. Having made it this far, we believe congratulations are in order. So we are brewing a few cups of stimulation, which is more exciting than usual since we recently restocked our pantry with a few interesting choices. For now, we are reaching for Mexican cinnamon.

Vaccines 154

Vaccines Diabetes 154

pharmaphorum

SEPTEMBER 4, 2024

Digital skills: Why private clinics need effective communication lines to bridge the growing digital divide Mike.

Communication 111

Communication 111

Med Ed 101

SEPTEMBER 4, 2024

JS is a 58-year-old female who has taken tramadol (podcast) for years due to chronic back pain. She has been experiencing worsening symptoms of depression and has been tried on duloxetine and sertraline in the past. Both of these medications caused GI upset and she is not interested in retrying these medications. The primary provider […] The post Tramadol and Fluoxetine Interaction appeared first on Med Ed 101.

90

90

Pharmaceutical Technology

SEPTEMBER 4, 2024

Actimed says S-oxprenolol shares a similar pharmacology to its lead product S-pindolol, which is being studied in cachexia.

105

105

pharmaphorum

SEPTEMBER 4, 2024

Regeneron signs up for access to a study run by Koneksa exploring the use of digital biomarkers to track patients with Parkinson's.

97

97

Express Pharma

SEPTEMBER 4, 2024

Lupin announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United States, after having received approval from the United States Food and Drug Administration (USFDA). Mirabegron Extended-Release Tablets, 50 mg is a generic equivalent of Myrbetriq Extended-Release Tablets, 50 mg of Astellas Pharma Global Development. Mirabegron Extended-Release Tablets, 50 mg had estimated annual sales of $ 1,600 million in the US (IQVIA MAT July 2024).

85

85

pharmaphorum

SEPTEMBER 4, 2024

Swiss startup Haya Therapeutics has formed a $1bn partnership with Eli Lilly to look for new therapies for obesity in non-coding DNA

97

97

Pharmaceutical Technology

SEPTEMBER 4, 2024

Merck has gained EC approval for KEYTRUDA plus Padcev for adults with unresectable or metastatic urothelial carcinoma.

101

101

Express Pharma

SEPTEMBER 4, 2024

NATCO Pharma announces that its wholly-owned Canadian subsidiary, NATCO Pharma (Canada), has made an investment of $ 8 million in eGenesis, a biotechnology company that is xenotransplantation focused on developing safe and effective human-compatible organs for transplant. In March 2024, eGenesis announced the world’s first porcine kidney transplant in a living patient.

79

79

Pharmaceutical Technology

SEPTEMBER 4, 2024

Pfizer Ignite will support Acepodia in developing its pipeline cancer therapeutic candidates.

98

98

Express Pharma

SEPTEMBER 4, 2024

Enzene Biosciences, a fully integrated CDMO with services spanning discovery, development and commercial supply, announced the appointment of Norm Stoffregen as SVP, site head, and head of biologics manufacturing at the company’s new $50 million manufacturing facility in Hopewell, near Princeton, New Jersey. Stoffregen will take responsibility for Enzene’s global biologics business and lead the final stages of work to commission the 54,000-square-foot facility.

74

74

World Pharma News

SEPTEMBER 4, 2024

Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs' protective barrier from healing after viral infections like COVID-19. The findings, published in Nature may lead to new therapeutic treatment options. The COVID-19 pandemic revealed how viral infections can cause long-lasting effects - a condition called long COVID.

Immunization 68

Immunization Immunity 68

Express Pharma

SEPTEMBER 4, 2024

Synthetic peptide therapeutics, encompassing a range of artificially created peptides, have emerged as a significant area of pharmaceutical development. Their specificity and safety profile make them a promising solution for addressing unmet medical challenges. Yet, alongside innovative modifications and intricate formulations emerge fresh hurdles. As this domain burgeons, sophisticated manufacturing, analytical tools, and refined data analysis become imperative for evaluating these peptides eff

64

64

BioPharma Dive

SEPTEMBER 4, 2024

A new dose regimen of Biogen's spinal muscular atrophy drug appeared promising, while Denali Therapeutics and Regenxbio charted plans for drug approval applications.

60

60